Dr. Schinstock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511Fax+1 515-241-8004
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Nephrology, 2008 - 2011
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2005 - 2008
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2005
Certifications & Licensure
- IA State Medical License 2011 - 2026
- MN State Medical License 2006 - 2025
- WI State Medical License 2021 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients Start of enrollment: 2019 Oct 14
- Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation Start of enrollment: 2023 Dec 07
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Socioeconomic Inequities in Preemptive Kidney Transplantation and Graft Survival: An Innovative Approach to Identifying Disparities in Kidney Transplantation.Sarah Kizilbash, Chung-Ii Wi, Madison Roy, Euijung Ryu, Arthur Matas
Transplantation Direct. 2025-01-01 - Physician-Directed Mycophenolate Mofetil Dose Reduction After Kidney Transplantation: A Multicenter Real Word Experience.Hani M Wadei, Namrata Parikh, Sarah Suliman, Ahmed Abdelrheem, Walter D Park
Transplantation Proceedings. 2024-12-01 - The Outcomes of Adenovirus Infection in Kidney Transplant Recipients.Hay Me Me, Sumi Nair, Carrie A Schinstock, Tambi Jarmi, Nan Zhang
Transplant Infectious Disease. 2024-11-16
Journal Articles
- Long‐Term Outcomes of Eculizumab‐Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor‐Specific AntibodiesMatthew Everly, Lynn D Cornell, Carrie A Schinstock, Andrew J Bentall, Mark D Stegall, American journal of transplantation
Press Mentions
- Kidney-Transplant Patients’ Survival BetterOctober 19th, 2021
- Mayo Clinic Minute: Long-Term Survival Improving for Kidney Transplant PatientsOctober 7th, 2021
- #MayoClinicRadio Podcast: 2/9/19February 11th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: